40 research outputs found

    Cosmological test using the high-redshift detection rate of FSRQs with the Square Kilometer Array

    Full text link
    We present a phenomenological method for predicting the number of Flat Spectrum Radio Quasars (FSRQs) that should be detected by upcoming Square Kilometer Array (SKA) SKA1-MID Wide Band 1 and Medium-Deep band 2 surveys. We use the Fermi Blazar Sequence and mass estimates of Fermi FSRQs, and gamma-ray emitting Narrow Line Seyfert 1 galaxies, to model the radio emission of FSRQs as a function of mass alone, assuming a near-Eddington accretion rate, which is suggested by current quasar surveys at z > 6. This is used to determine the smallest visible black hole mass as a function of redshift in two competing cosmologies we compare in this paper: the standard LCDM model and the R_h=ct universe. We then apply lockstep growth to the observed black-hole mass function at z=6z=6 in order to devolve that population to higher redshifts and determine the number of FSRQs detectable by the SKA surveys as a function of z. We find that at the redshifts for which this method is most valid, LCDM predicts ~30 times more FSRQs than R_h=ct for the Wide survey, and ~100 times more in the Medium-Deep survey. These stark differences will allow the SKA surveys to strongly differentiate between these two models, possibly rejecting one in comparison with the other at a high level of confidence.Comment: 8 pages, 5 figures, 3 tables. Accepted for publication in MNRA

    A Two-point Diagnostic for the HII Galaxy Hubble Diagram

    Full text link
    A previous analysis of starburst-dominated HII Galaxies and HII regions has demonstrated a statistically significant preference for the Friedmann-Robertson-Walker cosmology with zero active mass, known as the R_h=ct universe, over LCDM and its related dark-matter parametrizations. In this paper, we employ a 2-point diagnostic with these data to present a complementary statistical comparison of R_h=ct with Planck LCDM. Our 2-point diagnostic compares---in a pairwise fashion---the difference between the distance modulus measured at two redshifts with that predicted by each cosmology. Our results support the conclusion drawn by a previous comparative analysis demonstrating that R_h=ct is statistically preferred over Planck LCDM. But we also find that the reported errors in the HII measurements may not be purely Gaussian, perhaps due to a partial contamination by non-Gaussian systematic effects. The use of HII Galaxies and HII regions as standard candles may be improved even further with a better handling of the systematics in these sources.Comment: 7 pages, 6 figures, 2 tables. Accepted for publication in MNRA

    Analyzing H(z) Data using Two-point Diagnostics

    Full text link
    Measurements of the Hubble constant H(z) are increasingly being used to test the expansion rate predicted by various cosmological models. But the recent application of 2-point diagnostics, such as Om(z_i,z_j) and Omh^2(z_i,z_j), has produced considerable tension between LCDM's predictions and several observations, with other models faring even worse. Part of this problem is attributable to the continued mixing of truly model-independent measurements using the cosmic-chronomter approach, and model-dependent data extracted from BAOs. In this paper, we advance the use of 2-point diagnostics beyond their current status, and introduce new variations, which we call Delta h(z_i,z_j), that are more useful for model comparisons. But we restrict our analysis exclusively to cosmic-chronometer data, which are truly model independent. Even for these measurements, however, we confirm the conclusions drawn by earlier workers that the data have strongly non-Gaussian uncertainties, requiring the use of both "median" and "mean" statistical approaches. Our results reveal that previous analyses using 2-point diagnostics greatly underestimated the errors, thereby misinterpreting the level of tension between theoretical predictions and H(z) data. Instead, we demonstrate that as of today, only Einstein-de Sitter is ruled out by the 2-point diagnostics at a level of significance exceeding ~ 3 sigma. The R_h=ct universe is slightly favoured over the remaining models, including LCDM and Chevalier-Polarski-Linder, though all of them (other than Einstein-de Sitter) are consistent to within 1 sigma with the measured mean of the Delta h(z_i,z_j) diagnostics.Comment: 17 pages, 6 figures. Accepted for publication in MNRA

    Model Selection with Strong-lensing Systems

    Full text link
    In this paper, we use an unprecedentedly large sample (158) of confirmed strong lens systems for model selection, comparing five well studied Friedmann-Robertson-Walker cosmologies: LCDM, wCDM (the standard model with a variable dark-energy equation of state), the R_h=ct universe, the (empty) Milne cosmology, and the classical Einstein-de Sitter (matter dominated) universe. We first use these sources to optimize the parameters in the standard model and show that they are consistent with Planck, though the quality of the best fit is not satisfactory. We demonstrate that this is likely due to under-reported errors, or to errors yet to be included in this kind of analysis. We suggest that the missing dispersion may be due to scatter about a pure single isothermal sphere (SIS) model that is often assumed for the mass distribution in these lenses. We then use the Bayes information criterion, with the inclusion of a suggested SIS dispersion, to calculate the relative likelihoods and ranking of these models, showing that Milne and Einstein-de Sitter are completely ruled out, while R_h=ct is preferred over LCDM/wCDM with a relative probability of ~73% versus ~24%. The recently reported sample of new strong lens candidates by the Dark Energy Survey, if confirmed, may be able to demonstrate which of these two models is favoured over the other at a level exceeding 3 sigma.Comment: 19 pages, 2 figures, 2 tables. Accepted for publication in MNRA

    UNLV College of Education Multicultural & Diversity Newsletter

    Full text link
    Each morning I wound my way up the steep hill along the deeply rutted dirt path, exchanging daily maaa\u27s with five bleating sheep and shouting out, ÂĄHola! in response to the children who gleefully identified me as ÂĄGringa! Women and children, colorful bowls of cooked maize balanced atop their heads, sauntered to and from Maria Elena\u27s where their maize would be ground; at home the dough would be shaped and flattened into tortillas, the mainstay of every meal in the small Guatemalan village of San Juan

    UNLV College of Education Multicultural & Diversity Newsletter

    Full text link
    The workshop sponsored by the College of Education Multicultural & Diversity Committee on Friday January 16, 1998 was attended by approximately 40 faculty members and students from the College of Education. Dr. Gary Howard from the REACH Center (Respecting Ethnic And Cultural Heritage) located in Seattle, Washington provided an excellent three-hour workshop that asked attendees to ponder various dimensions of multicultural and global education. Dr. Howard provided information designed to facilitate the development of positive leadership skills for the implementation of cultural awareness and valuing diversity strategies in the classes in which the attendees teach---whether that be at a university or in a school distric

    Proceedings from the Ice Hockey Summit III: Action on Concussion

    Get PDF
    The Ice Hockey Summit III provided updated scientific evidence on concussions in hockey to inform these five objectives: 1) describe sport-related concussion (SRC) epidemiology, 2) classify prevention strategies, 3) define objective, diagnostic tests, 4) identify treatment, and 5) integrate science and clinical care into prioritized action plans and policy. Our action plan evolved from 40 scientific presentations. The 155 attendees (physicians, athletic trainers, physical therapists, nurses, neuropsychologists, scientists, engineers, coaches, and officials) voted to prioritize these action items in the final Summit session. 1) Establish a national and international hockey data base for SRC at all levels, 2) eliminate body checking in Bantam youth hockey games, 3) expand a behavior modification program (Fair Play) to all youth hockey levels, 4) enforce game ejection penalties for fighting in Junior A and professional hockey leagues, 5) establish objective tests to diagnose concussion at point of care (POC), and 6) mandate baseline testing to improve concussion diagnosis for all age groups. Expedient implementation of the Summit III prioritized action items is necessary to reduce the risk, severity, and consequences of concussion in the sport of ice hockey

    Proceedings from the Ice Hockey Summit III: Action on Concussion

    Get PDF
    Objectives The Ice Hockey Summit III provided updated scientific evidence on concussions in hockey to inform these five objectives: (1) describe sport related concussion (SRC) epidemiology, (2) classify prevention strategies, (3) define objective, diagnostic tests, (4) identify treatment and (5) integrate science and clinical care into prioritized action plans and policy. Methods Our action plan evolved from 40 scientific presentations. The 155 attendees (physicians, athletic trainers, physical therapists, nurses, neuropsychologists, scientists, engineers, coaches and officials) voted to prioritize these action items in the final Summit session. Results (1) establish a national and international hockey data base for SRCs at all levels; (2) eliminate body checking in Bantam youth hockey games; (3) expand a behavior modification program (Fair Play) to all youth hockey levels; (4) enforce game ejection penalties for fighting in Junior A and professional hockey leagues; (5) establish objective tests to diagnose concussion at point of care (POC); and (6) mandate baseline testing to improve concussion diagnosis for all age groups. Conclusions Expedient implementation of the Summit III prioritized action items is necessary to reduce the risk, severity and consequences of concussion in the sport of ice hockey

    Effect of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker initiation on organ support-free days in patients hospitalized with COVID-19

    Get PDF
    IMPORTANCE Overactivation of the renin-angiotensin system (RAS) may contribute to poor clinical outcomes in patients with COVID-19. Objective To determine whether angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB) initiation improves outcomes in patients hospitalized for COVID-19. DESIGN, SETTING, AND PARTICIPANTS In an ongoing, adaptive platform randomized clinical trial, 721 critically ill and 58 non–critically ill hospitalized adults were randomized to receive an RAS inhibitor or control between March 16, 2021, and February 25, 2022, at 69 sites in 7 countries (final follow-up on June 1, 2022). INTERVENTIONS Patients were randomized to receive open-label initiation of an ACE inhibitor (n = 257), ARB (n = 248), ARB in combination with DMX-200 (a chemokine receptor-2 inhibitor; n = 10), or no RAS inhibitor (control; n = 264) for up to 10 days. MAIN OUTCOMES AND MEASURES The primary outcome was organ support–free days, a composite of hospital survival and days alive without cardiovascular or respiratory organ support through 21 days. The primary analysis was a bayesian cumulative logistic model. Odds ratios (ORs) greater than 1 represent improved outcomes. RESULTS On February 25, 2022, enrollment was discontinued due to safety concerns. Among 679 critically ill patients with available primary outcome data, the median age was 56 years and 239 participants (35.2%) were women. Median (IQR) organ support–free days among critically ill patients was 10 (–1 to 16) in the ACE inhibitor group (n = 231), 8 (–1 to 17) in the ARB group (n = 217), and 12 (0 to 17) in the control group (n = 231) (median adjusted odds ratios of 0.77 [95% bayesian credible interval, 0.58-1.06] for improvement for ACE inhibitor and 0.76 [95% credible interval, 0.56-1.05] for ARB compared with control). The posterior probabilities that ACE inhibitors and ARBs worsened organ support–free days compared with control were 94.9% and 95.4%, respectively. Hospital survival occurred in 166 of 231 critically ill participants (71.9%) in the ACE inhibitor group, 152 of 217 (70.0%) in the ARB group, and 182 of 231 (78.8%) in the control group (posterior probabilities that ACE inhibitor and ARB worsened hospital survival compared with control were 95.3% and 98.1%, respectively). CONCLUSIONS AND RELEVANCE In this trial, among critically ill adults with COVID-19, initiation of an ACE inhibitor or ARB did not improve, and likely worsened, clinical outcomes. TRIAL REGISTRATION ClinicalTrials.gov Identifier: NCT0273570
    corecore